Recombinant Yersinia pseudotuberculosis serotype O:1b UPF0266 membrane protein YpsIP31758_2371 (YpsIP31758_2371)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Yersinia pseudotuberculosis Serotype O:1b UPF0266 Membrane Protein YpsIP31758_2371

The Recombinant Yersinia pseudotuberculosis serotype O:1b UPF0266 membrane protein YpsIP31758_2371 is a specific protein derived from the bacterium Yersinia pseudotuberculosis. This protein is expressed in Escherichia coli and is tagged with a His-tag for easier purification and identification. The full-length protein consists of 153 amino acids and is provided in a lyophilized powder form .

Amino Acid Sequence

The amino acid sequence of YpsIP31758_2371 is as follows: MSVTDLVLVVFIALLLIYAIYDEFIMNMMKGKTRLQVHLKRKNKLDCMIFVGLIGILIYN NVMAHGAPLTTYLLVGLALVAVYISYIRWPKLLFKNTGFFYANTFIEYSRIKSMNLSEDG ILVIDLEQRRLLIQVKKLDDLEKIYNFFIENQS .

Protein Structure and Function

Proteins like YpsIP31758_2371 have complex structures that are crucial for their functions. The tertiary structure of proteins, which is the three-dimensional conformation, is stabilized by disulfide bonds, hydrogen bonds, ionic bonds, and hydrophobic interactions . While specific functions of YpsIP31758_2371 are not detailed in available literature, proteins in general can serve various roles such as enzymatic activity, transport, and structural support.

Vaccine Development and Immunogenicity

Yersinia pseudotuberculosis has been explored as a potential tool in vaccine development, particularly for creating outer membrane vesicles (OMVs) that can serve as vaccines against pneumonic plague caused by Yersinia pestis . Although YpsIP31758_2371 is not directly mentioned in these studies, the use of Yersinia pseudotuberculosis strains highlights the potential for proteins from this bacterium to contribute to vaccine development.

ELISA Kits for Detection

Recombinant YpsIP31758_2371 is also available in ELISA kits, which are used for detecting antibodies against this protein. These kits are useful in research settings for studying immune responses to Yersinia pseudotuberculosis infections .

References

  1. Creative Biomart. Recombinant Full Length Yersinia pseudotuberculosis Serotype O:1b UPF0266 Membrane Protein YpsIP31758_2371 (YpsIP31758_2371) Protein, His-Tagged. [Accessed 2025].

  2. Study.com. Tertiary Structure of Protein | Overview, Diagram & Function. [Accessed 2025].

  3. PMC. Remodeling Yersinia pseudotuberculosis to generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague. [Accessed 2025].

  4. Colorectal Research. ELISA Recombinant Yersinia pseudotuberculosis serotype O:1b UPF0266 membrane protein YpsIP31758_2371 (YpsIP31758_2371). [Accessed 2025].

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
YpsIP31758_2371; UPF0266 membrane protein YpsIP31758_2371
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-153
Protein Length
full length protein
Species
Yersinia pseudotuberculosis serotype O:1b (strain IP 31758)
Target Names
YpsIP31758_2371
Target Protein Sequence
MSVTDLVLVVFIALLLIYAIYDEFIMNMMKGKTRLQVHLKRKNKLDCMIFVGLIGILIYN NVMAHGAPLTTYLLVGLALVAVYISYIRWPKLLFKNTGFFYANTFIEYSRIKSMNLSEDG ILVIDLEQRRLLIQVKKLDDLEKIYNFFIENQS
Uniprot No.

Target Background

Database Links
Protein Families
UPF0266 family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the genomic context of UPF0266 membrane protein YpsIP31758_2371 in Y. pseudotuberculosis?

The UPF0266 membrane protein YpsIP31758_2371 is encoded within the genome of Y. pseudotuberculosis strain IP31758, which has been fully sequenced and contains more than 260 strain-specific genes compared to other Y. pseudotuberculosis strains . When investigating this protein, researchers should examine its genomic neighborhood to identify potential operons or functionally related genes. This contextual analysis might reveal associations with virulence factors or metabolic pathways specific to the IP31758 strain associated with Far East scarlet-like fever (FESLF) .

Methodologically, researchers should:

  • Perform comparative genomic analysis with other Y. pseudotuberculosis strains

  • Identify conserved domains through bioinformatic tools

  • Analyze promoter regions for regulatory elements

  • Examine codon usage patterns to assess potential horizontal gene transfer

How does the classification as UPF0266 influence research approaches?

The UPF (Uncharacterized Protein Family) designation indicates that YpsIP31758_2371 belongs to a protein family with limited functional characterization. This classification should guide initial research approaches toward:

  • Structural prediction and modeling using homology-based tools

  • Functional prediction based on conserved domains

  • Comparative analysis with other UPF0266 family members across bacterial species

  • Expression pattern analysis under various environmental conditions

When approaching uncharacterized membrane proteins, researchers should implement a multifaceted strategy combining computational prediction and experimental validation, prioritizing techniques that can provide insights into membrane localization, topology, and potential binding partners.

What expression systems are most appropriate for recombinant production of YpsIP31758_2371?

For recombinant production of YpsIP31758_2371, researchers should consider several expression systems with the following methodological considerations:

Expression SystemAdvantagesLimitationsOptimization Strategies
E. coliHigh yield, cost-effective, rapid growthPotential incorrect folding, inclusion body formationFusion tags (MBP, SUMO), codon optimization, low-temperature induction
Yeast systemsBetter for eukaryotic membrane proteins, glycosylation capabilitySlower growth, complex media requirementsStrain selection, inducible promoters
Cell-free systemsAvoids toxicity issues, direct manipulation of reaction environmentLower yield, higher costSupplementation with lipids/detergents, optimization of redox conditions
Native Y. pseudotuberculosisNatural folding environmentPathogenicity concerns, lower yieldTemperature-regulated expression systems, attenuated strains

The selection should be guided by the specific research goals. For structural studies, E. coli with specialized membrane protein expression vectors might be optimal, while functional studies might benefit from expression in the native organism under controlled conditions.

How might YpsIP31758_2371 contribute to the unique pathogenicity profile of Y. pseudotuberculosis strain IP31758?

Y. pseudotuberculosis IP31758 is associated with Far East scarlet-like fever, which presents with distinct clinical manifestations including erythematous skin rash, desquamation, and toxic shock syndrome . Research approaches to investigate YpsIP31758_2371's potential role in this unique pathogenicity profile should include:

  • Generation of deletion mutants using CRISPR-Cas9 or allelic exchange methods

  • Complementation studies to confirm phenotypic changes

  • Infection models with appropriate cell lines and animal models

  • Transcriptomic and proteomic analyses comparing wild-type and mutant strains

The methodology should emphasize comparing the IP31758 strain with classical Y. pseudotuberculosis strains like IP32953 to identify strain-specific phenotypes. Given that IP31758 contains a type IVB secretion system similar to intracellular pathogens , researchers should investigate whether YpsIP31758_2371 interacts with this system or other virulence determinants.

What techniques are most effective for determining the membrane topology of YpsIP31758_2371?

Determining membrane topology is essential for understanding protein function. For YpsIP31758_2371, researchers should employ a combination of the following methodological approaches:

  • Computational prediction using algorithms like TMHMM, TOPCONS, and PredictProtein

  • Experimental validation through:

    • Reporter fusion techniques (PhoA/LacZ fusions at various positions)

    • Cysteine accessibility methods (SCAM)

    • Protease protection assays

    • Epitope tagging at predicted loops followed by immunofluorescence

When conducting these experiments, it's critical to maintain the protein in a native-like membrane environment. Researchers should consider using nanodiscs or liposomes derived from bacterial membranes to preserve functional conformations during analysis.

How does YpsIP31758_2371 interact with the host immune system during infection?

Considering that Y. pseudotuberculosis employs various mechanisms to evade host immunity, including the recruitment of complement regulators by outer membrane proteins like Ail , researchers investigating YpsIP31758_2371's potential immune interactions should:

  • Assess binding to host immune components using:

    • Pull-down assays with purified protein

    • Surface plasmon resonance for kinetic analysis

    • Co-immunoprecipitation from infected cells

  • Evaluate effects on immune signaling pathways:

    • NF-κB activation assays

    • Inflammasome activation studies

    • Cytokine profiling

  • Compare immune responses between wild-type and YpsIP31758_2371-deficient strains in:

    • Macrophage infection models

    • Dendritic cell activation assays

    • Complement resistance tests

The methodological approach should control for the influence of other known immune evasion factors, potentially using multiple knockout combinations to identify synergistic effects.

What are the optimal conditions for inducing and detecting YpsIP31758_2371 expression in Y. pseudotuberculosis?

Researchers should consider that Y. pseudotuberculosis differentially regulates gene expression in response to environmental conditions. For studying YpsIP31758_2371, the following methodological considerations are important:

Environmental FactorExperimental ConditionsDetection MethodControls
Temperature28°C (environmental) vs. 37°C (host)qRT-PCR, Western blotKnown temperature-regulated genes (invasin, YadA)
pHRange 5.5-8.0 (gastrointestinal transit)Reporter fusions, proteomicspH-responsive control genes
Nutrient availabilityMinimal vs. rich mediaRNA-seq, metabolic labelingHousekeeping genes
Host cell contactCo-culture with epithelial cellsMicroscopy, cell fractionationKnown adhesins (invasin, YadA)
Oxidative stressH₂O₂, NO donorsOxidative stress reportersKnown stress-responsive genes

When designing experiments to detect expression patterns, researchers should employ epitope tagging or fluorescent protein fusions at the C-terminus to minimize disruption of membrane insertion signals typically found at the N-terminus.

How should researchers approach structural studies of YpsIP31758_2371?

For structural characterization of YpsIP31758_2371, researchers should consider a hierarchical approach:

The methodological challenges include maintaining protein stability in detergent or membrane mimetics. Researchers should test multiple extraction and purification conditions, possibly incorporating stabilizing mutations or antibody fragments to facilitate crystallization.

What strategies should be employed to identify potential binding partners of YpsIP31758_2371?

Identifying interaction partners is crucial for functional characterization. Researchers should implement:

  • Unbiased screening approaches:

    • Bacterial two-hybrid systems adapted for membrane proteins

    • Co-immunoprecipitation followed by mass spectrometry

    • Proximity labeling techniques (BioID, APEX)

    • Chemical cross-linking coupled with mass spectrometry

  • Candidate-based approaches:

    • Direct binding assays with purified components

    • Bacterial surface display for host factor screening

    • Yeast two-hybrid with membrane protein adaptations

When performing these experiments, appropriate controls must include non-specific membrane proteins of similar size and topology. For Y. pseudotuberculosis specifically, researchers should investigate potential interactions with known virulence factors such as the type IVB secretion system components found in strain IP31758 .

How should researchers distinguish between direct and indirect effects in functional studies of YpsIP31758_2371?

When analyzing phenotypes of YpsIP31758_2371 mutants, researchers must consider:

  • Complementation strategies:

    • Expression of wild-type protein from various promoters

    • Site-directed mutagenesis of key residues

    • Conditional expression systems

  • Control experiments:

    • Multiple independent mutant strains

    • Whole-genome sequencing to confirm absence of secondary mutations

    • Transcriptomics to identify compensatory changes

  • Approaches to establish causality:

    • Time-course experiments with inducible systems

    • Dose-response relationships with tunable expression

    • Epistasis analysis with related pathway components

What bioinformatic approaches are most valuable for predicting the function of YpsIP31758_2371?

For uncharacterized proteins like YpsIP31758_2371, computational analysis can provide valuable functional insights:

  • Sequence-based approaches:

    • Profile hidden Markov models to identify distant homologs

    • Co-evolution analysis to predict interaction interfaces

    • Genomic context (gene neighborhood) analysis

  • Structure-based approaches:

    • Threading algorithms for fold recognition

    • Binding site prediction based on surface electrostatics

    • Molecular docking with potential ligands

  • Systems-based approaches:

    • Co-expression network analysis across conditions

    • Phylogenetic profiling to identify functional associations

    • Integration with pathogen-host interaction databases

Researchers should critically evaluate computational predictions by assessing confidence scores and validating key predictions experimentally, particularly when the protein belongs to an uncharacterized family with limited reference data.

How might YpsIP31758_2371 contribute to bacterial adaptation during host infection?

Research into adaptation mechanisms should consider:

  • Experimental approaches:

    • In vivo passage experiments with recovery and sequencing

    • Single-cell gene expression analysis during infection

    • Fitness measurements in different host microenvironments

  • Comparative studies:

    • Analysis across Y. pseudotuberculosis isolates from different clinical presentations

    • Expression patterns relative to other virulence factors

    • Contribution to fitness in competition assays

Given that Y. pseudotuberculosis IP31758 causes distinctive clinical symptoms compared to classical strains , researchers should investigate whether YpsIP31758_2371 contributes to this unique pathogenicity profile, particularly in relation to the strain's capacity to cause Far East scarlet-like fever.

What are the challenges and solutions in developing antibodies or other detection reagents for YpsIP31758_2371?

For researchers developing detection tools, the following methodological considerations are important:

  • Antigen design strategies:

    • Identification of extracellular loops based on topology predictions

    • Synthetic peptides versus recombinant protein fragments

    • Conformational epitopes preserved in detergent micelles

  • Validation approaches:

    • Testing specificity across related Yersinia species

    • Confirmation using knockout strains

    • Assessment of sensitivity in complex samples

  • Alternative detection strategies:

    • Aptamer development through SELEX

    • Nanobody generation using camelid immunization

    • Activity-based probes if functional activity is identified

The development of high-quality detection reagents is critical for subsequent localization studies, quantification during infection, and potential diagnostic applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.